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LIST OF ABBREVIATIONS  
BF%, percentage body fat  
BFM, body fat mass  
BLM, body lean mass 
BMI, body mass index 
DF, dorsiflexor  
DXA, dual-energy X-ray absorptiometry  
GM, gastrocnemius medialis  
IL-(1-8), interleukin-(1-8)  
Lf, fascicle length  
MVC, maximum voluntary contraction  
PCSA, physiological cross-sectional area  
PF, plantar flexor  
TNF-α, tumour necrosis factor-α  
Vm, muscle volume  
p, fascicle pennation angle  
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ABSTRACT 
Background/Objectives: The purpose of this study was to determine whether circulating pro-
inflammatory cytokines, elevated with increased fat mass and ageing, were associated with muscle 
properties in young and older people with variable adiposity.  
Subjects/Methods: Seventy-five young (18-49 yrs) and 67 older (50-80 yrs) healthy, untrained men 
and women (BMI: 17-49 kg/m
2
) performed isometric and isokinetic plantar flexor maximum 
voluntary contractions (MVCs). Volume (Vm), fascicle pennation angle (FPA), and physiological 
cross-sectional area (PCSA) of the gastrocnemius medialis (GM) muscle were measured using 
ultrasonography. Voluntary muscle activation (VA) was assessed using electrical stimulation. GM 
specific force was calculated as GM fascicle force/PCSA. Percentage body fat (BF%), body fat mass 
(BFM), and lean mass (BLM) were assessed using dual-energy X-ray absorptiometry. Serum 
concentration of 12 cytokines was measured using multiplex luminometry.  
Results: Despite greater Vm, FPA, and PCSA (p<0.05), young individuals with BF% ≥40 exhibited 
37% less GM specific force compared to young BF% <40 (p<0.05). Older adults with BF% ≥40 
showed greater isokinetic MVC compared to older BF% <40 (p=0.019) but this was reversed when 
normalised to body mass (p<0.001). IL-6 correlated inversely with VA in young (r=-0.376; p=0.022) 
but not older adults (p>0.05), while IL-8 correlated with VA in older but not young adults (r≥0.378, 
p≤0.027). TNF-alpha correlated with MVC, lean mass, GM FPA and maximum force in older adults 
(r≥0.458; p≤0.048). 
Conclusions: The age- and adiposity-dependent relationships found here provide evidence that 
circulating pro-inflammatory cytokines may play different roles in muscle remodelling according to 
the age and adiposity of the individual. 
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INTRODUCTION  
Obesity, defined as a body mass index (BMI) ≥30, is a major global public health concern, with over 
500 million people worldwide classified as overweight or obese 
1
. As well as being linked to 
metabolic disorders 
2-4
, the maximum muscle strength produced by obese individuals is significantly 
less than that generated by non-obese people when normalised to body mass 
5
, limb lean mass 
6
, or to 
the muscle physiological cross-sectional area (PCSA) 
7
. This could lead to major functional 
limitations for daily living activities, such as climbing/descending stairs, rising from a chair, 
recovering from a trip, etc., which in turn could lead to hospitalisation and reduced quality of life.  
 
There are a number of reasons why muscle quality (defined here as muscle specific force, i.e. the 
maximum force per unit PCSA) might be lower in obese vs. non-obese people. Fat infiltration within 
the skeletal muscle reduces the contractile component of the total muscle volume 
8
, thereby lowering 
the intrinsic strength of the whole muscle 
9
. Furthermore, intramuscular lipid acts as a 
chemoattractant for macrophages 
10
, which produce pro-inflammatory cytokines 
11
, such as tumour 
necrosis factor-alpha (TNF-α) 12 and interleukin-6 (IL-6) 13. This chronic immune response is 
characterised by elevated concentrations of these pro-inflammatory cytokines in the blood resulting 
in chronic low-grade systemic inflammation, which has been observed in young 
12, 14
 and older 
15
 
obese people. To compound this problem, both adipocytes 
16
 and macrophages 
11
 secrete pro-
inflammatory cytokines, and it has been suggested that fat accounts for approximately 30% of serum 
IL-6 levels in humans 
17
. Thus, a chronically inflamed environment is created within and around the 
muscle containing substantial intramuscular fat. Crucially, as well as acting as chemoattractants, these 
cytokines are directly involved in the breakdown of muscle protein 
18
. This would interfere with the 
accretion of contractile material caused by the chronic low-intensity overloading of the muscle 
19
, thus 
reducing muscle specific force. However, it is unclear to what extent chronic inflammation is 
responsible for the reduction in muscle quality and muscle function in obese individuals.   
©    2016 Macmillan Publishers Limited. All rights reserved.
5 
 
 
As well as the increase in obesity incidence, we are living for longer. This is particularly relevant, as 
ageing is associated with a decrease in muscle activation capacity 
20
, loss of muscle size 
21
, a 
decrease in the fascicle pennation angle 
22
, i.e. the angle at which the fascicles insert into the lower 
aponeurosis [the smaller the muscle fibre CSA, the smaller the pennation angle 
23
], and reduced 
muscle strength, both at the whole muscle and fascicle levels 
21
. Collectively, these physiological 
changes in muscle properties with age lead to senile sarcopaenia, which is thought to be a major 
factor underlying the incidence of falls and reduced quality of life in older people 
24
. Furthermore, 
ageing is associated with increased intramuscular fat 
25, 26
, which is likely a major cause of 
chronically elevated levels of pro-inflammatory circulating cytokines 
27, 28
 and lower muscle specific 
force 
21
 in older vs. younger adults. Furthermore, central inflammation, i.e. elevated pro-
inflammatory cytokines in the hippocampus and hypothalamus, leads to neuroinflammation 
29
, which 
might help explain the lower neuromuscular activation and absolute strength commonly observed in 
older vs. younger individuals 
6, 20, 21, 30
. Moreover, as a high fat diet can elevate pro-inflammatory 
cytokine expression and activate the pro-inflammatory transcription factor nuclear factor-κB (NF-
κB) in the hypothalamus 31, it is feasible that a higher fat diet in both young and older obese 
individuals could have reduced ability to activate their muscles compared to leaner persons due to 
neuroinflammation.  
 
Although both obesity and ageing can lead to chronic low grade systemic inflammation, it is not 
known if systemic inflammation in obese older adults signifies a cumulative negative impact of both 
ageing and obesity on skeletal muscle properties. Therefore, the aim of this study was to determine 
whether circulating pro-inflammatory cytokines, elevated with increased fat mass 
12, 32, 33
 and ageing 
27, 28, 34
, could explain the different effects of obesity on skeletal muscle size, architecture and 
strength between young and older adults. We hypothesised that pro-inflammatory cytokines would 
©    2016 Macmillan Publishers Limited. All rights reserved.
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be associated with lower muscle size and strength in both young obese and older individuals. 
Further, we hypothesised that circulating pro-inflammatory cytokine concentration would be 
inversely correlated with neuromuscular activation and strength in older and obese people.   
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SUBJECTS AND METHODS 
Subjects 
142 healthy, untrained men and women gave their written informed consent to participate in this 
study, which complied with the Declaration of Helsinki 
35
 and was approved by the local ethics 
committee of Manchester Metropolitan University. Participants were categorised according to total 
body fat percentage (normal: <40%; high: ≥40% for females 7, 36, 37, and normal: <28%; high: ≥28% 
for males 
36
) and age (young: 18-49 yrs; older: 50-80 yrs), and their physical characteristics are 
shown in Table 1. Within the total cohort, there were 75 young (56 women, 22 men) and 67 older (48 
women, 19 men) participants (Table 1). Of the younger group, 35 women and 17 men were normal 
BF%, and 19 women and 4 men were high BF%. Of the older group, 19 women and 4 men were 
normal BF%, and 29 women and 15 men were high BF%. Volunteers were screened for general 
health and habitual physical activity via questionnaire prior to participation. Exclusion criteria 
included history of lower limb muscle/tendon/joint disorders that affected mobility or the ability to 
exert maximum plantar-/dorsiflexor force; any chronic inflammatory condition; immunosuppressant 
medication; pregnancy; history of lower-limb resistance training in the six months prior to the start 
of the study; participation in >2 hourly sessions of structured physical activity a week; cognitive 
impediments.  
 
Experimental design 
Participants visited the laboratory on three separate occasions within 14 days. During the first 
session, participants provided a fasted 10 mL venous blood sample, from which serum levels of 12 
inflammatory cytokines were quantified, and a sub-sample of participants were instructed how to use 
a 3-day food and drink diary, which was used to analyse habitual dietary fat intake. All 142 
participants were subsequently familiarised to the muscle function assessments, which consisted of 
isometric and isokinetic plantar flexor (PF) and dorsiflexor (DF) maximum voluntary contractions 
©    2016 Macmillan Publishers Limited. All rights reserved.
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(MVCs), and ramp isometric PF contractions to measure gastrocnemius medialis (GM) muscle 
architecture (fascicle length, Lf, and pennation angle, p). On the second visit, participants completed 
a full body dual-energy X-ray absorptiometry (DXA) scan in the fasted state to assess total body 
composition. GM muscle volume was then determined from axial ultrasound scans and muscle 
length in 127 (men, n=32; women, n=95) participants. On the third and final visit, participants 
repeated the muscle function assessments, and the highest MVC scores from either the 
familiarisation or third laboratory session were used for subsequent analysis. The muscle function 
and morphology measurements were all performed on the dominant limb. Joint torque, joint angle, 
electromyographic (EMG) activity and electrical stimulation signals were interfaced with an 
analogue-to-digital converter (Biopac Systems Inc, Santa Barbara, USA), sampled at 2,000 Hz and 
displayed on the screen of an iMac computer (Apple, Cupertino, USA) using AcqKnowledge 
software (Biopac Systems).  
 
Body composition  
Participants a whole body DXA scan (Discovery W, Hologic Inc., Bedford, USA) between 08:00 and 
09:00 after a 12 h fast. Total body fat mass, lean mass, and body fat percentage (BF%), were 
calculated using Hologic APEX software (version 3.3). 
 
Dietary fat intake 
Habitual dietary fat profiles of a subsample of 61 subjects were assessed using a three-day food diary 
recorded over two weekdays (Thursday and Friday) and one weekend day (Saturday). Subjects 
recorded their eating and drinking habits in as much detail as possible, e.g. time of meal, weight of 
food/ingredients in grams and volume of drink in mL, commercial brand names of food/ingredients 
and drink, any leftovers and cooking preparation methods. Dietary analysis was conducted using 
Nutritics software (version 1.8, Nutritics Ltd., Co. Dublin, Ireland). From the food analysis, dietary 
©    2016 Macmillan Publishers Limited. All rights reserved.
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fat (absolute values and normalised to body mass) for each subject was calculated as an average over 
the three-day period. 
 
Neuromuscular measurements  
PF and DF MVCs 
Participants sat on the chair of an isokinetic dynamometer (Cybex Norm, Cybex International, New 
York, USA) with a hip angle of 85 (180 corresponding to the supine position) and were firmly 
strapped at the hip, distal thigh and chest with inextensible straps to minimise extraneous movement. 
The dominant leg was fully extended and the foot was securely fastened to the dynamometer 
footplate with the lateral malleolus aligned with the axis of rotation. Participants performed 2-3 
isometric PF and DF MVCs (iMVCs) for 2-3 s (alternating between PF and DF every 60 s) at each of 
the following ankle joint positions: -5 (DF), 0 (neutral position, foot 90 to tibia) and 10 (PF). DF 
iMVCs were performed to obtain maximum DF EMG, in order to calculate antagonist co-activation 
during PF iMVC (see below). Participants also performed three consecutive isokinetic PF MVCs 
(ikMVCs) at 60·s-1 from -5 to 10. 
 
Antagonist muscle co-activation 
After appropriate skin preparation, two bipolar Ag-AgCl surface EMG electrodes (Neuroline, 
Medicotest, Rugmarken, Denmark) were placed 20 mm apart along the sagittal axis over the 
proximal third of the tibialis anterior (TA) muscle belly (SENIAM), with a reference electrode 
positioned over the lateral tibial condyle. The EMG signal was pre-amplified (× 2,000) and filtered 
using high- and low-pass filters set at 10 and 500 Hz, respectively (plus notch filter at 50 Hz). The 
root mean square (RMS) of the EMG signal was calculated over 1 s around the peak torque during 
each PF and DF MVC at all three joint angles. Thus, antagonist torque output during PF iMVC was 
calculated by dividing TA EMG RMS during PF iMVC by TA EMG RMS during DF iMVC, and 
©    2016 Macmillan Publishers Limited. All rights reserved.
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multiplying DF iMVC torque by this ratio. The sum of the antagonist torque and PF iMVC torque 
was used to calculate maximum Achilles tendon force and GM muscle specific force (see below).  
 
Voluntary muscle activation 
The level of voluntary muscle activation was measured using the interpolated twitch technique (ITT) 
during the PF iMVCs with the joint set at 0. Electrical muscle stimulation was administered 
percutaneously to the PF muscle group via two 5 × 10 cm self-adhesive electrodes (American Imex, 
Irvine, USA) placed distal to the popliteal crease (cathode) and the myotendinous junction of the 
soleus (anode). A supramaximal doublet (two twitch stimuli of 0.2 ms pulse width, administered at 
100 Hz) was manually applied at rest (control doublet) 3 s before iMVC, and once during iMVC. 
The level of voluntary muscle activation was given by: 
100 × (1 – t/T) 
where t is the force of the superimposed doublet and T is the force of the control doublet. This 
percentage was used to calculate the maximum isometric torque able to be produced by the PF group 
(PF max torque) at each joint angle, as shown below:  
PF max torque = PF iMVC (corrected for co-activation) / (1 – t/T) 
 
Achilles tendon moment arm 
The tendon excursion method using B-mode ultrasonography (AU5 Harmonic, Esaote Biomedica, 
Genoa, Italy), as described previously 
38, 39
, was used to determine the Achilles tendon moment arm. 
Participants were secured to the dynamometer chair and foot-plate (ankle set at 0), as described 
above. A 2 mm wide, 2 cm long strip of surgical tape (3M, Neuss, Germany) was attached to the 
skin, transversely over the GM myotendinous junction (MTJ). The 4 cm wide, 7.5 MHz linear array 
ultrasound probe was then positioned sagitally over the tape to record the passive movement of the 
GM MTJ while the ankle was rotated between the angles of -5 and 10 at a constant velocity of 1·s-
©    2016 Macmillan Publishers Limited. All rights reserved.
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1
. The ultrasound scan (including three continuous PF and DF rotations) was synchronised with the 
joint angle signal via a square wave signal generator. The displacement of the MTJ between 10° and 
-5° was measured with image analysis software (ImageJ, National Institutes of Health, Bethesda, 
USA) and the Achilles tendon moment arm at 0° was calculated as the MTJ displacement divided by 
change in the joint angle during a complete rotation (15°). 
 
Achilles tendon force (Ft) 
Ft was calculated by dividing PF max torque by the Achilles tendon moment arm.  
 
Muscle volume 
GM muscle volume (Vm) was measured with B-mode ultrasonography (AU5 Harmonic), using 
previously described methods validated in the vastus lateralis muscle 
40
. Participants lay relaxed in 
the prone position with the ankle angle set to 0. The proximal end (0%) and 25, 50, 75 and 100% 
(distal end) of the GM muscle were located and marked on the skin. At 25, 50 and 75% muscle 
length, the lateral and medial boundaries were located and marked on the skin. The ultrasound probe 
was subsequently orientated in the axial plane, aligned perpendicular to the GM muscle, and moved 
along each pre-marked axial line at 25%, 50% and 75% muscle length. Individual frames were 
exported and used to re-construct the anatomical cross-sectional areas (ACSAs) of the GM at 25%, 
50% and 75% muscle length using image-editing software (Photoshop, Adobe Systems Europe Ltd, 
Maidenhead, UK). Each of the three ACSAs was then measured using ImageJ. GM muscle volume 
(Vm) was then calculated by treating the muscle as a series of truncated cones 
40
. Each of the four 
truncated cones was calculated using the following equation, where d is the distance between two 
ACSAs (a and b):  
𝑉m =
1
3
∙ 𝑑 ∙  𝑎 +  𝑎 ∙ 𝑏 + 𝑏  
The sum of the four cones provided the total GM Vm.  
©    2016 Macmillan Publishers Limited. All rights reserved.
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GM muscle architecture and PCSA 
With the ankle joint set at 0, the ultrasound probe was placed sagitally over the centre of the GM 
muscle, in line with the direction of the fascicles. The participant performed a ramped PF iMVC, 
gradually increasing torque over the course of 6 s. The frame depicting the GM muscle architecture 
at peak PF iMVC was exported and fascicle pennation angle (p, the angle at which the fascicles 
insert into the lower aponeurosis) and length (Lf) were measured using ImageJ. The mean of the 
three p and Lf measurements were subsequently used to calculate GM muscle fascicle force (GM Ff) 
and GM physiological cross-sectional area (PCSA), respectively (see below). 
 
GM muscle fascicle force (Ff) 
Based on the relative proportion of GM muscle volume to total PF muscle volume 
41
, the 
contribution of GM muscle to Ft was assumed to be 20.3%. Therefore, GM Ff was calculated by 
dividing Ft by the cosine of GM p, as shown below:  
GM Ff = (Ft · 0.203) / cosp 
 
GM muscle PCSA and specific force 
GM PCSA at iMVC was calculated as GM Vm / Lf. Subsequently, dividing GM Ff by GM PCSA 
provided GM muscle specific force.  
 
Serum inflammatory cytokine concentration 
Participants provided a 10 ml fasted blood sample at 08:00 and 09:00 having performed no strenuous 
exercise for 48 h. Blood was collected in to an anticoagulant free vacutainer (BD Vacutainer 
Systems, Plymouth, UK) and serum prepared and stored in 2 ml aliquots at -20C until subsequent 
analysis. Seventy-eight serum samples were randomly selected for cytokine analysis from a list of 
©    2016 Macmillan Publishers Limited. All rights reserved.
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participant numbers with BMI and age as a guide for selection (the investigator was blinded to all 
other participant information). Consequently, 39 young and 39 older (n=48 BF% <40; n=31 BF% 
≥40) participants were selected for analysis. Serum concentrations of eight inflammatory cytokines 
(pro-inflammatory: IL-1β, IL-6, TNF-α, G-CSF; anti-inflammatory: IL-10, TGF-β1, TGF-β2, TGF-
β3) and four chemokines (IL-8, MCP-1, MIP-1α, MIP-1β) were measured using multiplex 
luminometry. A 3-plex panel was used to measure TGF-β1, β2 and β3 concentrations (R&D Systems 
Europe Ltd, Abingdon, UK) and a Bio-Plex Pro Human Inflammation Panel Assay (Bio-Rad 
laboratories Ltd., Hemel Hempstead, UK) was used to measure the remaining nine cytokines, 
following the manufacturer’s instructions. Samples were analysed using a Bio-Plex 200 system (Bio-
Rad laboratories Ltd., Hemel Hempstead, UK).   
 
Statistical analyses  
IBM SPSS statistics (version 23, SPSS Inc., Chicago, IL) was used for all analyses. Two-way 
ANOVAs with Scheffe post hoc tests were used to determine the main effects of age, adiposity, and 
interaction for all of the study parameters. A Freidman’s ANOVA was used to compare between 
days differences in dietary fat content. Bivariate Pearson correlations were used to ascertain 
relationships between the serum concentration of individual inflammatory cytokines, and fat/muscle 
characteristics. Partial correlations (controlling for total body fat mass) were performed to determine 
the relationships between inflammatory cytokine concentration and muscle variables independently 
of fat mass. Partial correlations (controlling for age) were performed to determine the relationships 
between inflammatory cytokine concentration and muscle variables independently of age. Statistical 
significance was accepted when P ≤ 0.05. Data are presented as means ± SD unless otherwise stated. 
©    2016 Macmillan Publishers Limited. All rights reserved.
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RESULTS  
 
Anthropometry, body composition  
The younger individuals were taller (P < 0.05), had a greater body mass (P < 0.05) and greater lean 
mass (P < 0.05) than the older persons (Table 1). There was no effect of adiposity on total body lean 
mass (P > 0.05), although there was a tendency for the young high BF% group to have greater lean 
mass than the older high BF% group (ANOVA, age × adiposity, P = 0.055). Young high BF% also 
presented with higher body mass, BMI and fat mass than the other three groups (P < 0.05; Table 1). 
As expected, adiposity was positively associated with body mass, BMI and BF% (all, P < 0.05) 
(Table 1).  
 
Insert Table 1 here.  
 
Maximum strength  
PF isometric and isokinetic MVC ankle joint torque  
Regarding absolute iMVC, there was a main effect of age: young individuals produced higher PF 
iMVC compared to older persons (P < 0.001; Table 1). There was also a main effect of adiposity, 
with high adipose persons being stronger than those of normal adiposity (P = 0.007). However, there 
was no age  adiposity interaction (P = 0.289; Table 1). Regarding absolute PF ikMVC, there was a 
main effect of age: young individuals produced higher ikMVC compared to older persons (P < 
0.001). There was no main effect of adiposity (P = 0.128; Table 1) and no age  adiposity interaction 
(P = 0.396; Table 1).  
 
Maximum Achilles tendon force (Ft) 
There was a main effect of age, i.e. young individuals produced greater Ft compared to older persons 
(P < 0.001; Table 1), and a main effect of adiposity, with high adipose persons producing greater 
©    2016 Macmillan Publishers Limited. All rights reserved.
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force than normal adipose individuals (P = 0.020), but there was no age  adiposity interaction (P = 
0.472; Table 1).  
 
Maximum GM fascicle force (Ff) 
There was a main effect of age, i.e. younger individuals produced greater Ff than older persons (P < 
0.001; Table 1), and there was a main effect of adiposity (P = 0.002), with high adipose persons 
producing more force than normal adipose individuals. However, there was no age  adiposity 
interaction (P = 0.237; Table 1).  
 
Maximum strength normalised to muscle size  
After normalising iMVC and ikMVC to GM Vm, there were main effects for age on iMVC/Vm, i.e. 
older persons had lower iMVC/Vm and ikMVC/Vm than young individuals (P < 0.05; Table 1), and 
there were main effects for adiposity (P < 0.05; Table 1), with normal demonstrating greater muscle 
quality than high adipose persons. There were also age  adiposity interactions (P < 0.05), i.e. young 
individuals with normal BF% had greater muscle quality compared to all other groups (P < 0.05; 
Table 1). Regarding GM muscle specific force, there were no main effects of age or adiposity, or any 
interaction between age and adiposity (P > 0.05; Table 1). 
 
Voluntary muscle activation capacity 
There were significant main effects for both age (P = 0.001; Table 1) and adiposity (P = 0.011; Table 
1), demonstrating that young individuals had higher muscle activation capacity than older persons, 
and that persons with high BF% (regardless of age) had lower activation capacity than persons with 
normal BF%. There was no age  adiposity interaction (P = 0.185; Table 1).  
 
Muscle morphology  
©    2016 Macmillan Publishers Limited. All rights reserved.
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GM muscle volume and PCSA 
There were main effects for age on GM Vm and PCSA: young persons had larger Vm and PCSA than 
older individuals (P < 0.001; Table 1); and main effects for adiposity: persons with high BF% had 
larger Vm and PCSA than persons with normal BF% (P < 0.001; Table 1). There were also age  
adiposity interactions: young persons with high BF% had larger muscle volume and PCSA than all 
other groups (P < 0.001; Table 1).  
 
GM muscle architecture  
There were main effects for both age (P < 0.05; Table 1) and adiposity (P < 0.05; Table 1), i.e. 
young persons had larger GM p than older individuals, while persons with high BF% had larger p 
than persons with normal BF% (P < 0.05; Table 1). However, there was no age  adiposity 
interaction with GM p (P > 0.05). Further, there were no effects of age (P > 0.05; Table 1) or 
adiposity (P > 0.05; Table 1), and there was no age  adiposity interaction (P > 0.05; Table 1) with 
GM fascicle length.  
 
Insert Table 1 here.  
 
Serum inflammatory cytokine concentration  
Associations with age and/or adiposity 
Serum IL-6 concentration showed a significant main effect for age (P = 0.004), with older 
participants having higher serum concentrations than young individuals (Table 2). There was no 
main effect of adiposity, and no interaction between age and adiposity (P > 0.05). There was also an 
age  adiposity interaction (P = 0.016) regarding serum MCP-1, with older individuals of high 
adiposity having higher levels than older normal adipose persons. Finally, there was a main effect of 
©    2016 Macmillan Publishers Limited. All rights reserved.
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adiposity concerning TGF-β2 (P = 0.008), with high adipose persons having a greater serum 
concentration of this cytokine than those of normal adiposity (Table 2).  
 
Insert Table 2 here.  
 
Correlations with muscle and fat phenotypes in young and older persons combined 
The positive and inverse relationships between serum IL-6, IL-1β, MCP-1, MIP-1α and MIP-1β 
concentrations and adiposity and muscle properties in young and older individuals combined are 
shown in Table 3.  
 
Insert Table 3 here.  
 
Correlations with muscle and fat phenotypes in young persons only 
The inverse correlation between serum IL-6 concentration and voluntary activation and, after 
controlling for BF%, the partial correlation between serum IL-6 and voluntary activation are shown 
in Table 4. Likewise, the inverse correlations between serum IL-1β and BMI, iMVC, ikMVC, fat 
mass, lean mass, GM PCSA, GM p, (r ≥ -0.325; P ≤ 0.049), and between serum MIP-1α and BF% 
(r = -0.343; P = 0.035) and fat mass (r = -0.323; P = 0.048) are displayed in Table 4. The positive 
correlations between serum MIP-1β and iMVC, GM Vm, GM Lf, Ft, GM PCSA, (r ≥ 0.339; P ≤ 
0.040) and inverse correlation with ikMVC/Vm (r = -0.402; P = 0.028) are also shown in Table 4. 
 
Correlations with muscle and fat phenotypes in older persons only 
Serum MCP1 correlated positively with BMI, BF% and fat mass (r ≥ 0.378; P ≤ 0.028; Table 4). 
Serum TNF-α correlated positively with iMVC, ikMVC, lean mass, GM p, Ft, GM Ff, (r ≥ 0.458; P 
≤ 0.048; Table 4). After controlling for total body fat mass, TNF-α correlated with iMVC, lean mass, 
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GM p, GM Ff, (r ≥ 0.510; P ≤ 0.044; Table 4). Serum IL-8 correlated positively with voluntary 
muscle activation (r = 0.382; P = 0.016; Table 4), and controlling for fat mass strengthened this 
correlation (r = 0.414; P = 0.010; Table 4).  
 
Insert Table 4 here.  
 
Correlations with muscle and fat phenotypes in persons of normal and high adiposity  
The positive and inverse relationships between serum IL-6, IL-1β, IL-8, TNF-α, MCP-1, MIP-1β, 
and G-CSF concentrations and adiposity and muscle properties in persons of normal and high 
adiposity are shown in Table 5. Most notably, IL-6 correlated inversely with on muscle quality in 
both normal and high adipose individuals (r ≥ -0.367; P ≤ 0.042; Table 5), MIP-1β correlated with 
numerous measures of maximum muscle force and size in normal adipose persons (r ≥ 0.332; P ≤ 
0.039; Table 5), and IL-8 correlated inversely with measures of muscle strength and quality in high 
adipose individuals (r ≥ -0.364; P ≤ 0.044; Table 5), but positively with muscle quality in persons of 
normal adiposity (r = 0.604; P = 0.038; Table 5).  
 
Insert Table 5 here.  
 
Habitual dietary fat intake 
A Friedman’s ANOVA revealed no between days difference (P = 0.448) between daily fat intake 
over the three-day dietary analysis period. For daily absolute fat intake, there was a main effect for 
age with young individuals consuming more fat than older persons (P = 0.041; Table 6). There was 
no main effect for adiposity (P = 0.088; Table 6) but there was an age  adiposity interaction, with 
young normal consuming more fat than all other groups (P < 0.05) but otherwise no other differences 
(P > 0.05). For daily fat intake normalised to body mass, there was no main effect for age (P > 0.05) 
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but there was a main effect for adiposity (P < 0.001; Table 6), with normal consuming more fat than 
high. There was also an age  adiposity interaction (P = 0.021; Table 6): young normal and old 
normal consumed per fat than both young high and old high. Concerning the daily amount of fat 
consumed as a percentage of total energy intake, there was no main effect of age (P = 0.869) but 
there was a main effect for adiposity (P = 0.043) and an age  adiposity interaction (P = 0.025; Table 
6), with normal young consuming a greater percentage of fat compared to high young (P = 0.014). 
Finally, regarding the daily amount of fat consumed as a percentage of total macronutrient intake, 
there was no main effect of age (P = 0.696) or adiposity (P = 0.070), and no age  adiposity 
interaction (P = 0.161; Table 6).  
 
Insert Table 6 here.  
 
Correlations between habitual dietary fat content and cytokines 
In young persons only, serum IL-1β (r = 0.976; P = 0.010) and IL-8 (r = 0.879; P = 0.021) correlated 
with absolute (g/day) fat intake. In older persons only, TGF-β3 correlated with fat intake, both in 
absolute terms (r = 0.567; P = 0.022) and normalised to body mass (r = 0.509; P = 0.044). In young 
and older individuals combined, TGF-β3 correlated positively with daily fat intake, both in absolute 
terms (r = 0.561; P = 0.015) and normalised to body mass (r = 0.512; P = 0.030).  
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DISCUSSION 
We aimed to determine whether circulating inflammatory cytokine levels could explain the different 
effects of obesity on skeletal muscle size, architecture and strength previously reported in young vs. 
older adults. Our data suggest that, in young adults, serum IL-6 has a negative impact on 
neuromuscular activation, while IL-1β has a negative, and MIP-1β a positive, influence on muscle 
size, structure and strength (Table 4). In older adults, elevated IL-8 was positively associated with 
greater neuromuscular activation, while unexpectedly, TNF-α correlated positively with muscle 
mass, architecture and maximum strength (Table 4). In persons of normal adiposity, MIP-1β appears 
to play a very positive role in muscle size and strength, while IL-8 has a largely negative relationship 
with muscle quality (maximum strength normalised to either muscle size or body mass) in high 
adipose individuals (Table 5).  
 
In line with previous research, we have shown that serum IL-6 concentration was higher in older vs. 
young adults 
27, 28
. Furthermore, IL-6 correlated with BMI, total body fat mass and BF% in young 
and older individuals combined, which is in line with previous work 
32
. Moreover, the inverse 
relationship between IL-6 and voluntary muscle activation was particularly interesting given the 
positive relationships between IL-6 and adiposity reported here (Table 3) and elsewhere 
12, 14, 15
, and 
between IL-6 and ageing 
27, 28
. This inverse relationship (even after controlling for BF%) strongly 
suggests that IL-6 has a negative effect on the ability to voluntarily activate skeletal muscle. This 
may well be influenced by central inflammation, i.e. elevated levels of IL-6 and other pro-
inflammatory cytokines in the hippocampus and hypothalamus (induced by a high fat diet
31
), which 
lead to neuroinflammation
29
. This potentially reduces an individual’s ability to activate their muscles 
voluntarily, thus impairing muscle size and function. Not only might this help explain the 
significantly lower muscle activation and absolute strength values in older vs. younger individuals 
reported here and elsewhere 
6, 20, 21, 30
, but it might also explain the lower muscle activation capacity 
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we found here in young and older persons with high vs. normal BF%. Although we did not find a 
relationship between IL-6 and habitual dietary fat intake, we did observe positive relations between 
fat intake and other pro-inflammatory cytokines (IL-1β and IL-8).  
 
IL-8 is a chemokine that acts as a neutrophil chemotactic factor 
42
 and is therefore pro-inflammatory. 
It has previously been associated with obesity 
43
, which coincides with our finding of higher (though 
non-significant) serum IL-8 levels in older persons with high BF% compared to older lean and 
younger adults. Surprisingly, we found that serum IL-8 correlated positively with voluntary muscle 
activation in older adults. As IL-8 is known to induce angiogenesis 
42
, enhance endothelial cell 
proliferation and have an anti-apoptotic effect 
44
, it is possible that this chemokine provides a 
protective, or rescuing, effect against neuroinflammation in older adults.  
 
Both TNF-α mRNA content and TNF-α production are elevated in adipose tissue of obese 
individuals 
12
, while circulating TNF-α concentration also rises with obesity 45. We found a non-
significant trend for serum TNF-α to correlate inversely with iMVC, and a significant inverse 
correlation between serum IL-1β and muscle size and strength and adiposity in young adults. In 
contrast, TNF-α correlated positively with iMVC, ikMVC, lean mass, GM p, maximum tendon 
force and GM fascicle force in older adults, thus suggesting age-dependent effects of TNF-α on 
skeletal muscle characteristics. After controlling for fat mass, TNF-α remained positively correlated 
with older muscle size and strength. This indicates the effect of TNF-α was not due to fat mass per 
se, which is supported by TNF-α being produced almost exclusively by macrophages within adipose 
tissue, as opposed to the adipocytes themselves 
11
. Skeletal muscle also produces TNF-α 46 and, 
although it has catabolic properties (thus possibly explaining the inverse correlation with iMVC in 
young adults), it has been shown to stimulate protein synthesis 
47
 and positively influence maximum 
strength 
48
 during the various phases of muscle remodelling. Furthermore, TNF-α induces IL-6 
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production in myoblasts 
49
 and IL-6, in combination with TNF-α, stimulates myoblast growth 50. 
Therefore, it is feasible that the muscles of those older individuals with elevated serum TNF-α 
produced more IL-6, thus having a beneficial rather than deleterious effect on muscle size and 
strength.  
 
In contrast to our TNF-α results, serum MIP-1β, correlated positively with muscle size, architecture 
and absolute strength in young adults, and with numerous measures of muscle size, structure and 
strength in persons of normal adiposity. MIP-1β is a chemoattractant for monocytes 51 and interacts 
with MIP-1α 52, which correlated inversely with adiposity in our young participants. Thus, it appears 
that these chemokines have a positive effect on skeletal muscle properties in young but not in older 
muscle, and may therefore explain the previously reported lower muscle quality in older vs. young 
adults 
21
.  
 
Our study has highlighted novel relationships between numerous circulating cytokines and precise 
measures of neuromuscular properties in young and older individuals of varied adiposity. These 
relationships indicate potential mechanisms that may explain the lower muscle quality in obese vs. 
normal weight individuals 
7
, and in older vs. younger persons 
21
, seen here and elsewhere. However, 
we acknowledge certain limitations with our study; as cognitive function was not a focus of this 
study (although our selection criteria excluded cognitively challenged volunteers), it is not possible 
to make a direct comparison with those previous studies that associated high levels of IL-6 with 
cognitive decline 
29
). Furthermore, contrary to our hypothesis based on previous work 
31
, our data did 
not exhibit any association between habitual dietary fat intake and circulating IL-6 (although we did 
observe positive correlations between fat intake and IL-β1 and IL-8 in young persons). Nevertheless, 
our reported inverse relationship between IL-6 and voluntary muscle activation in young individuals 
is as expected in a physiological system linking high IL-6 with poor neuronal integration. Future 
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human studies should consider these parameters (cognition, IL-6 endocrine profile, and diet) 
longitudinally. We would also recommend that studies employing an animal model may wish to 
build on previous work
31
, by characterising neurodegeneration and muscle size and strength in young 
vs. old animals fed with a high vs. low fat diet. In older persons, we found that IL-8 correlated 
positively with voluntary activation but, to our knowledge, there is no evidence linking IL-8 with 
neurogenesis or repair following damage due to ageing. Future studies may wish to investigate this 
potential protective mechanism against neurodegeneration in older persons by measuring the effect 
of high vs. low doses of IL-8 on damaged neurons in vitro and on neurological properties in an 
animal model in vivo. Finally, our somewhat surprising relationships between TNF-α and muscle 
size and strength in older persons only may be explained by TNF-α acting in a dose-response manner 
to reduce the rate of sarcopenia. Indeed in cell culture models, a concentration of this cytokine (as 
well as dependent on the order in which various cytokines are introduced in the culture dish), the 
effects of TNF-α can either induce hypertrophy or alternatively, muscle breakdown 50, 53. 
 
To conclude, our data suggest that obesity has a greater anabolic effect on young compared to older 
human muscle, but that it attenuates muscle quality more in young compared to older adults. The 
inverse relationship between serum IL-6 and voluntary muscle activation in young adults, and the 
chronically elevated levels of IL-6 and lower voluntary muscle activation levels in older adults, 
suggest that IL-6-induced neuroinflammation plays a role in reducing voluntary muscle strength. 
Interestingly, the unexpected positive relationship between IL-8 and voluntary muscle activation in 
older adults suggests this chemokine may be differentially impacting neuroinflammation and hence 
neuromuscular activation. The positive relationship between TNF-α and muscle mass and strength in 
older adults in the current cohort, whilst potentially supporting previous reports of TNF-α having a 
positive effect on skeletal muscle properties, is yet to be fully understood given the weight of the 
previous published evidence pertaining to the contrary (i.e. a deleterious muscle protein synthesis 
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and/or stimulatory impact on the rate of protein degradation). Collectively, these age- and adiposity-
dependent relationships provide evidence that circulating pro-inflammatory cytokines play different 
roles in neuromuscular remodelling according to the age and adiposity of the individual.   
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Table 1. Body composition and gastrocnemius medialis (GM) muscle strength (n=142), size and architecture (n=127) of 
the study participants according to age and BF%.. Values are mean ± SD. 
 
Table 2. The serum concentration of pro-inflammatory cytokines in 12-78 study participants (the number of participants 
varies according to the ability to measure certain cytokines in the serum). Values are mean ± SE.   
 
Table 3. Correlations between inflammatory cytokines and measures of adiposity and muscle characteristics (with and 
without controlling for fat mass) in young and older persons combined. Inverse correlations are highlighted in grey.  
 
Table 4. Correlations between inflammatory cytokines and measures of adiposity and muscle characteristics [with and 
without controlling for BF% or fat mass (FM)] according to age (young vs. older persons). Inverse correlations are 
highlighted in grey. 
 
Table 5. Correlations between inflammatory cytokines and measures of adiposity and muscle characteristics (with and 
without controlling for age) according to adiposity (normal vs. high). Inverse correlations are highlighted in grey. 
 
Table 6. Habitual dietary fat intake measured using a 3-d food and drink diary (Thurs-Sat). Values are mean ± SD. 
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Table 1. Body composition and gastrocnemius medialis (GM) muscle strength (n=142), size and architecture 
(n=127) of the study participants according to age and BF%.. Values are mean ± SD.  
Variable Young (n=75) Older (n=67) 
 Normal BF% 
(n=52) 
High BF% 
(n=23) 
Normal BF% 
(n=23) 
High BF% 
(n=44) 
Age (yrs) 24.04 ± 8.42 28.04 ± 9.69 65.52 ± 7.98* 66.02 ± 7.29* 
Height (m) 1.70 ± 0.10 1.68 ± 0.08 1.63 ± 0.09* 1.65 ± 0.06* 
Body mass (kg) 65.56 ± 13.50 94.93 ± 14.13†^ 62.23 ± 14.13* 79.65 ± 14.64*† 
BMI (m/kg
2
) 22.75 ± 3.87 33.81 ± 4.86†^ 23.16 ± 3.43* 29.23 ± 5.33*† 
Body fat (%) 27.59 ± 6.92^ 43.30 ± 6.56† 32.31 ± 9.93 40.60 ± 7.04† 
Body fat mass (kg) 17.70 ± 6.42 40.13 ± 8.85†^ 19.59 ± 5.72* 31.64 ± 9.70*† 
Body lean mass (kg) 43.62 ± 9.53 49.60 ± 8.26† 38.89 ± 9.67* 43.26 ± 8.14*† 
iMVC PF torque (N·m) 173.64 ± 44.17 200.75 ± 42.92† 133.37 ± 36.60* 145.20 ± 34.41*† 
ikMVC PF torque (N·m) 92.34 ± 25.18 102.00 ± 21.10 60.51 ± 20.83* 63.27 ± 20.85* 
VA (%) 95.29 ± 5.51  88.02 ± 11.04†  86.58 ± 14.15*  84.28 ± 12.05*†  
Ft (N)  5245 ± 1357  5949 ± 1631†  4026 ± 1079*  4400 ± 1055*†  
GM Ff (N)  1221 ± 334  1471 ± 427†  930 ± 274*  1042 ± 273*†  
GM Vm (cm
3
)  214.59 ± 61.61  310.75 ± 59.37†^  203.66 ± 43.24*  217.11 ± 49.19*†  
GM p ()  30.58 ± 5.09  35.10 ± 3.95†  27.71 ± 4.73*  30.36 ± 4.60*†  
GM Lf (cm)  3.65 ± 0.58  3.73 ± 0.54  3.94 ± 0.78  3.86 ± 0.60  
GM PCSA (cm
2
)  60.20 ± 16.52  85.86 ± 18.00†^  52.50 ± 13.23*  57.14 ± 13.93*†  
iMVC/BM (N·m/kg)  2.59 ± 0.58 1.99 ± 0.36† 2.10 ± 0.41* 1.71 ± 0.34*† 
ikMVC/BM (N·m/kg)  1.43 ± 0.28 1.09 ± 0.25† 0.97 ± 0.25* 0.80 ± 0.25*† 
iMVC/Vm (N·m/cm
3
) 0.81 ± 0.18^ 0.65 ± 0.14† 0.66 ± 0.14 0.68 ± 0.15† 
©    2016 Macmillan Publishers Limited. All rights reserved.
ikMVC/Vm (N·m/cm
3
) 0.43 ± 0.12^ 0.34 ± 0.09† 0.30 ± 0.10* 0.30 ± 0.08*† 
GM specific force (N/cm
2
)  21.07 ± 5.85  17.59 ± 5.28  18.35 ± 5.33  18.80 ± 4.72 
BMI, body mass index; iMVC, isometric maximum voluntary contraction; ikMVC, isokinetic maximum 
voluntary contraction; VA, voluntary muscle activation; Ft, maximum Achilles tendon force; GM Ff, 
gastrocnemius medialis fascicle force; Vm, muscle volume; p, muscle fascicle pennation angle; Lf, muscle 
fascicle length; PCSA, physiological cross-sectional area; BM, body mass; *significant effect of age (P < 0.05); 
†significant effect of BF% (P < 0.05); ^significant age x BF% interaction (P < 0.05).  
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Table 2. The serum concentration of pro-inflammatory cytokines in 12-78 study participants (the number of 
participants varies according to the ability to measure certain cytokines in the serum). Values are mean ± SE.  
Cytokine Young (n=39) Older (n=39) 
 (pg/mL) Normal BF%  
(n=28) 
High BF%  
(n=11) 
Normal BF%  
(n=11) 
High BF%  
(n=28) 
IL-1β  1.03 ± 0.17  0.69 ± 0.17    0.70 ± 0.18  0.72 ± 0.12  
IL-6  0.93 ± 0.16  1.28 ± 0.19    1.78 ± 0.26*  2.09 ± 0.22*  
IL-8  9.53 ± 0.93  8.59 ± 1.43    8.35 ± 1.00  11.80 ± 1.07  
IL-10  3.51 ± 0.64   2.95 ± 0.59  2.29 ± 0.29  4.20 ± 0.86  
TNF-α  3.90 ± 0.78  3.12 ± 1.21    3.69 ± 1.32  4.84 ± 1.01  
MCP-1  208 ± 44  114 ± 29  85 ± 22  329 ± 73^  
MIP-1α  3.81 ± 0.65  2.03 ± 0.37    2.45 ± 0.59  1.94 ± 0.23  
MIP-1β  101 ± 23  101 ± 29  68 ± 12  126 ± 31  
G-CSF  28.50 ± 5.70  13.41 ± 4.78  21.69 ± 15.45  45.12 ± 12.34  
TGF-β1  32,261 ± 7539  29,193 ± 9,041  12,625 ± 2,003  38,862 ± 6,596  
TGF-β2  341 ± 33  413 ± 92† 200 ± 21  407 ± 43†  
TGF-β3  273 ± 84  184 ± 63  122 ± 37  334 ± 69  
IL-10: IL-6 3.55 ± 0.79 5.17 ± 1.32 1.61 ± 0.31 3.76 ± 1.01 
IL-1β, interleukin-1β; TNF-α, tumour necrosis factor- α; MCP-1, monocyte chemoattractant protein-1; MIP-1α, 
macrophage inflammatory protein-1α; MIP-1β, macrophage inflammatory protein-1β; G-CSF, granulocyte-
colony stimulating factor; TGF-β1, transforming growth factor-β1; *significant effect of age (P < 0.05); 
†significant effect of BF% (P < 0.05); ^significant age x BF% interaction (P < 0.05).  
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Table 3. Correlations between inflammatory cytokines and measures of adiposity and muscle characteristics 
(with and without controlling for fat mass, FM) in young and older persons combined. Inverse correlations are 
highlighted in grey.  
Variable 
 
Serum cytokine concentration (pg/mL) 
 
 
IL-6 IL-6 
(FM) 
IL-1β MCP1 MIP-1α MIP-1β 
BMI (kg/m
2
) r=0.326; 
p=0.008 
 r=-0.318; 
p=0.005 
r=0.251; 
p=0.047 
r=-0.209; 
p=0.074 
 
BF% r=0.357; 
p=0.003 
 r=-0.332; 
p=0.003 
r=0.297; 
p=0.018 
r=-0.378; 
p=0.001 
 
FM (kg) r=0.380; 
p=0.002 
 r=-0.335; 
p=0.003 
r=0.341; 
p=0.006 
r=-0.306; 
p=0.008 
 
VA (%) r=-0.370; 
p=0.002 
r=-0.311; 
p=0.022 
  r=0.234; 
p=0.046 
 
ikMVC (N·m) r=-0.279; 
p=0.024 
r=-0.317; 
p=0.020 
    
ikMVC/Vm (N·m/cm
3
) r=-0.355; 
p=0.008 
r=-0.260; 
p=0.057 
r=0.258; 
p=0.038 
 r=0.238; 
p=0.068 
 
ikMVC/BM (N·m/kg) r=-0.470; 
p<0.001 
r=-0.344; 
p=0.011 
  r=0.267; 
p=0.022 
 
iMVC/BM (N·m/kg) r=-0.455; 
P<0.001 
r=-0.307; 
p=0.024 
r=0.271; 
p=0.018 
 r=0.258; 
p=0.027 
 
iMVC/Vm (N·m/cm
3
) r=-0.257; 
p=0.058) 
     
GM Vm (cm
3
)      r=0.267; 
p=0.032 
GM PCSA (cm
2
)      r=0.216; 
p=0.084 
BMI, body mass index; FM, fat mass; VA, voluntary muscle activation; iMVC, isometric maximum voluntary 
contraction; ikMVC, isokinetic maximum voluntary contraction; GM Vm, gastrocnemius medialis muscle 
volume; PCSA, physiological cross-sectional area. 
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Table 4. Correlations between inflammatory cytokines and measures of adiposity and muscle characteristics [with and without controlling for BF% or fat mass (FM)] 
according to age (young vs. older persons). Inverse correlations are highlighted in grey.  
Variable Serum cytokine concentration (pg/mL) 
 
 
 
IL-6 IL-6 
(BF%) 
IL-1β MIP-1α MIP-1β MCP-1 TNF-α TNF-α  
(FM) 
IL-8 IL-8  
(FM) 
           
 
 
Young individuals Older individuals 
BMI (kg/m
2
)   r = -0.330;  
p = 0.043 
  r = 0.378;  
p = 0.028 
    
BF%    r = -0.343;  
p = 0.001 
 r = 0.428;  
p = 0.011 
    
FM (kg)   r = -0.357;  
p = 0.028 
r = -0.323;  
p = 0.048 
 r = 0.514;  
p = 0.002 
    
LM (kg) 
 
  r = -0.360;  
p = 0.026 
   r = 0.645;  
p = 0.003 
r = 0.655;  
p = 0.003 
  
VA (%) r = -0.376;  
p = 0.022 
r = -0.362;  
p = 0.050 
      r = 0.382;  
p = 0.016 
r = 0.414;  
p = 0.010 
iMVC 
(N·m) 
  r = -0.333;  
p = 0.044 
 r = 0.356;  
p = 0.030 
 r = 0.588;  
p = 0.008 
r = 0.589;  
p = 0.010 
  
ikMVC 
(N·m) 
  
 
r = -0.325;  
p = 0.049 
   r = 0.483;  
p = 0.036 
   
ikMVC/Vm 
(N·m/cm
3
) 
    r = -0.402;  
p = 0.028 
     
Ft (N) 
 
    r = 0.339;  
p = 0.040 
 r = 0.492;  
p = 0.032 
   
GM Ff (N) 
 
      r = 0.534;  
p = 0.019 
r = 0.535;  
p = 0.022 
  
GM Vm 
(cm
3
) 
    r = 0.566;  
p = 0.001 
     
GM θp () 
 
  r = -0.414;  
p = 0.013 
   r = 0.458;  
p = 0.048 
r = 0.482;  
p = 0.043 
  
GM Lf (mm) 
 
    r = 0.393;  
p = 0.019 
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GM PCSA 
(cm
2
) 
  r = -0.409;  
p = 0.025 
 r = 0.386;  
p = 0.035 
     
BMI, body mass index; FM, fat mass; LM, lean mass; VA, voluntary muscle activation; iMVC, isometric maximum voluntary contraction; ikMVC, isokinetic maximum 
voluntary contraction; Ft, maximum Achilles tendon force; GM Ff, maximum gastrocnemius medialis muscle fascicle force; GM Vm, gastrocnemius medialis muscle volume; 
θp, fascicle pennation angle; Lf, fascicle length; PCSA, physiological cross-sectional area. 
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Table 5. Correlations between inflammatory cytokines and measures of adiposity and muscle characteristics (with and without controlling for age) according to adiposity 
(normal vs. high). Inverse correlations are highlighted in grey.  
Variable Serum cytokine concentration (pg/mL) 
  
 
 
IL-6 IL-1β IL-1β    
(age) 
IL-8      
(age) 
TNF-α MIP-1β MIP-1β 
(age) 
IL-6 IL-8 IL-8 
(age) 
MCP-1 
(age) 
G-CSF G-CSF 
(age) 
MIP-1β 
(age) 
               
 
 
Normal adiposity (n = 39) High adiposity (n = 39) 
BMI (kg/m
2
)      r=0.386;  
p=0.015 
        
BF%  r=-0.391;  
p=0.014 
            
FM (kg)  r=-0.417;  
 =0.008 
   r=0.332;  
p=0.039 
    r=0.507;  
p=0.010 
   
iMVC 
(N·m) 
     r=0.363;  
p=0.025 
  r=-0.396;  
p=0.014 
     
ikMVC 
(N·m) 
  
 
   r=0.457;  
p=0.004 
r=0.793;  
p=0.022 
       
Ft (N) 
 
     r=0.393;  
p=0.015 
  r=-0.412;  
p=0.010 
r=-0.364;  
p=0.044 
    
GM Ff (N) 
 
     r=0.387;  
p=0.016 
  r=-0.401;  
p=0.013 
     
Sp. force 
(N/cm
2
) 
         r=-0.432;  
p=0.015 
 r=0.594;  
p=0.009 
r=0.848;  
p=0.033 
 
iMVC/Vm 
(N·m/cm
3
) 
    r=0.517;  
p=0.040 
    r=-0.456;  
p=0.010 
   r=0.901;  
p=0.014 
ikMVC/Vm 
(N·m/cm
3
) 
  r=0.643;  
 =0.024 
r=0.604;  
 =0.038 
          
iMVC/BM 
(N·m/kg) 
       r=-0.378;  
p=0.028 
      
ikMVC/BM 
(N·m/kg) 
r=-0.367;  
p=0.042 
             
GM Vm 
(cm
3
) 
     r=0.695;  
p<0.001 
r=0.868;  
p<0.001 
       
GM PCSA      r=0.550;  r=0.739;         
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(cm
2
) p=0.001 p=0.006 
BMI, body mass index; FM, fat mass; LM, lean mass; VA, voluntary muscle activation; iMVC, isometric maximum voluntary contraction; ikMVC, isokinetic maximum 
voluntary contraction; Ft, maximum Achilles tendon force; GM Ff, maximum gastrocnemius medialis muscle fascicle force; GM Vm, gastrocnemius medialis muscle volume; 
Sp. force, gastrocnemius muscle specific force; θp, fascicle pennation angle; Lf, fascicle length; PCSA, physiological cross-sectional area. 
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Table 6. Habitual dietary fat intake measured using a 3-d food and drink diary (Thurs-Sat). Values are mean ± 
SD.  
Measure of fat intake Young (n=15) Older (n=46) 
 Normal BF% 
(n=10) 
High BF%  
(n=5) 
Normal BF% 
(n=14) 
High BF% 
(n=32) 
Absolute fat intake     
(g/d) 
98.45 ± 31.18^ 68.76 ± 20.80† 66.40 ± 16.20* 72.93 ± 18.79*† 
Fat intake normalised to 
body mass (g/kg/d) 
1.31 ± 0.47^ 0.70 ± 0.19† 1.11 ± 0.26^ 0.93 ± 0.23† 
% fat of total energy 
intake (%) 
35.90 ± 5.71^  28.40 ± 7.20†  32.23 ± 4.53  32.64 ± 5.31†  
% fat of total 
macronutrient  intake (%) 
20.90 ± 3.45  17.20 ± 4.15  18.85 ± 3.24  18.85 ± 3.61  
*Significant effect of age (P < 0.05); †significant effect of BF% (P < 0.05); ^significant age x BF% interaction 
(P < 0.05).  
 
©    2016 Macmillan Publishers Limited. All rights reserved.
